نتایج جستجو برای: double dose vaccination

تعداد نتایج: 591550  

Journal: :The Pediatric infectious disease journal 2013
Paolo Bonanni Anne Gershon Michael Gershon Andrea Kulcsár Vassiliki Papaevangelou Bernard Rentier Catherine Sadzot-Delvaux Vytautas Usonis Timo Vesikari Catherine Weil-Olivier Peter de Winter Peter Wutzler

BACKGROUND Two-dose varicella vaccination is recommended for optimal control of varicella in populations with high (>90%) 1-dose coverage. Optimal timing of the second dose may depend on whether breakthrough varicella results from primary vaccine failure (no protective immunity after vaccination) or secondary vaccine failure (waning protective immunity). METHODS Published literature (1995 to ...

Journal: :Vaccine 2013
Carlos A DiazGranados Andrew J Dunning Emilia Jordanov Victoria Landolfi Martine Denis H Keipp Talbot

BACKGROUND High-dose trivalent influenza vaccine was developed to improve antibody responses to influenza vaccine in the elderly and hence potentially impact favorably on influenza-associated morbidity and mortality in this population. METHODS A phase IIIb, multicenter, randomized, double-blind, controlled trial was conducted to compare High-Dose (HD) trivalent inactivated influenza vaccine (...

Journal: :Vaccine 2007
Sven-Eric Olsson Luisa L Villa Ronaldo L R Costa Carlos A Petta Rosires P Andrade Christian Malm Ole-Erik Iversen John Høye Margareta Steinwall Grete Riis-Johannessen Agneta Andersson-Ellstrom Kristina Elfgren Geo von Krogh Matti Lehtinen Jorma Paavonen Gretchen M Tamms Katherine Giacoletti Lisa Lupinacci Mark T Esser Scott C Vuocolo Alfred J Saah Eliav Barr

BACKGROUND The duration of protection afforded by vaccines represents a critical test of their utility as public health interventions. Some vaccines induce long-term immunity, while others require booster doses. Vaccines that induce long-term protection are usually characterized by the generation of immune memory. Recent trials of a quadrivalent (types 6, 11, 16, 18) human papillomavirus (HPV) ...

2014
Adriana S. Lopez Cristina Cardemil Laura J. Pabst Karen A. Cullen Jessica Leung Stephanie R. Bialek

In 2007, the Advisory Committee on Immunization Practices (ACIP) recommended a routine second dose of varicella vaccine for children at age 4-6 years, in addition to the first dose given at age 12-15 months. One strategy recommended for increasing varicella vaccination coverage is a school entry requirement of proof of varicella immunity. To determine the extent of implementation of the routine...

Journal: :Vaccine 2004
Gustavo H Dayan Lisa Cairns Nalinee Sangrujee Anne Mtonga Van Nguyen Peter Strebel

The vaccination program in Zambia includes one dose of measles vaccine at 9 months of age. The objective of this study was to compare the cost-effectiveness of the current one-dose measles vaccination program with an immunization schedule in which a second dose is provided either through routine health services or through supplemental immunization activities (SIAs). We simulated the expected co...

2013
Freya J. I. Fowkes Rose McGready Simon Johnstone-Robertson François Nosten James G. Beeson

TO THE EDITOR—Maternal and neonatal tetanus is a significant cause of mortality, estimated to cause 180 000 deaths annually [1]. Since the mid-1970s, tetanus vaccination of pregnant women has been included in the World Health Organization’s (WHO) Expanded Programme on Immunisation (EPI) [2]. Two doses of tetanus toxoid are sufficient to generate an antibody response (immunoglobulin G [IgG] clas...

Journal: :East African medical journal 2009
Y Berhane W W Schluter F Oyewole O A Babaniyi

BACKGROUND Although measles vaccination is recommended to be given at nine months of age in Ethiopia and in most of sub-Saharan Africa, no information is available about the age at which children actually receive their first dose of measles vaccine. This has important implications in terms of preventing infection and averting epidemics of measles. OBJECTIVE To determine the age at which Ethio...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008
C L Cooper J B Angel I Seguin H L Davis D W Cameron

BACKGROUND Human immunodeficiency virus (HIV)-infected persons are hyporesponsive to hepatitis B virus (HBV) vaccination. CPG 7909 is an oligodeoxynucleotide containing immunostimulatory CpG motifs that activate human B and plasmacytoid dendritic cells via Toll-like receptor 9. We previously reported that addition of CPG 7909 to a commercial HBV vaccine enhanced the kinetics, magnitude, and lon...

Journal: :The New England journal of medicine 2002
Sharon E Frey Frances K Newman John Cruz W Brian Shelton Janice M Tennant Tamara Polach Alan L Rothman Jeffrey S Kennedy Mark Wolff Robert B Belshe Francis A Ennis

BACKGROUND We conducted a double-blind, randomized trial of three dilutions of vaccinia virus vaccine in previously unimmunized adults in order to assess the clinical success rates, humoral responses, and virus-specific activity of cytotoxic T cells and interferon-gamma-producing T cells. METHODS Sixty healthy adults were inoculated intradermally by bifurcated needle with undiluted vaccine (d...

Journal: :Vaccine 2013
Lisa A Jackson Alejandra Gurtman Kathryn Rice Karlis Pauksens Richard N Greenberg Thomas R Jones Daniel A Scott Emilio A Emini William C Gruber Beate Schmoele-Thoma

BACKGROUND The currently recommended single dose of the 23-valent pneumococcal free polysaccharide vaccine (PPSV23) for adults 65 years of age and older does not provide extended protection into older age. This reflects a significant unmet medical need for alternative strategies to protect older adults against pneumococcal infection, which may be met by the 13-valent polysaccharide conjugate va...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید